Acasti Pharma Inc. (CVE:ACST – Get Free Report) rose 1.8% on Tuesday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Up 1.8%
The firm has a market cap of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22. The stock has a 50 day moving average price of C$0.58 and a two-hundred day moving average price of C$0.58.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
